HRT FINANCIAL LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1475597 NEW YORK, NY

Position in RARE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$12,847,147

+$1,308,530 QoQ

Shares Held

613,229

+22.2% QoQ

Ownership

0.623%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. RARE ranks #7 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc. This page	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,847,147	613,229	+22.2%	Shares	Defined	2026-05-14
2025-12-31	$11,538,617	501,679	+528.5%	Shares	Defined	2026-02-12
2025-06-30	$2,902,400	79,824	+131.8%	Shares	Defined	2025-08-14
2025-03-31	$1,246,891	34,435	+20.8%	Shares	Defined	2025-05-15
2024-12-31	$1,198,995	28,500	+20.4%	Shares	Defined	2025-02-14
2024-09-30	$1,315,146	23,675	+200.9%	Shares	Defined	2024-11-12
2024-03-31	$367,403	7,869	-57.0%	Shares	Defined	2024-05-13
2023-12-31	$875,058	18,299	-69.1%	Shares	Defined	2024-02-09
2023-06-30	$2,735,509	59,300	+466.8%	Shares	Defined	2023-08-11
2023-03-31	$419,526	10,462	-65.7%	Shares	Defined	2023-05-12
2022-12-31	$1,412,323	30,484	-80.6%	Shares	Defined	2023-02-10
2021-06-30	$14,964,991	156,948	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.